Skip to content

Avaulta versus anterior colporraphy

A randomised controlled trial comparing the clinical and cost-effectiveness of the Avaulta anterior mesh and the standard anterior colporraphy for the primary surgical treatment of a cystocele stage ≥ 2

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON21781
Enrollment
115
Registered
2008-07-14
Start date
2007-05-23
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anterior prolapse surgery

Interventions

Women are either allocated to a group who will undergo a classic anterior colporraphy repair or a group in which the Avaulta&reg
mesh is used

Sponsors

University Medical Center Utrecht (UMCU)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Women aged 40-80 years 2. Cystocele stage ¡Ý 2 according to POP Q classification 3. No previous anterior colporraphy 4. Good understanding of Dutch language in word en writing

Exclusion criteria

Exclusion criteria: 1. Women with childbearing potential who do not use adequate contraceptive measures (hormonal contraceptives, barrier methods (condoms), intra uterine device, male vasectomy, sterilisation). 2. History of major gynaecological or urological surgery, with the exception of a hysterectomy for reasons other than a genital prolapse. 3. History of cancer or severe cardiopulmonary disease 4. Conditions that might interfere with a successful conduction and completion of the study in the opinion of the specialist (language problems, cognitive dysfunction, etc) 5. Recurrent lower urinary tract infections (> 3 culture proven infections/year) 6. Maximum bladder capacity < 300 ml (bladder diary) 7. Urinary stress incontinence with an indication for surgical correction.

Design outcomes

Primary

MeasureTime frame
The number of women who will have a recurrence, defined as a stage ¡Ý 2 anterior vaginal prolapse at 2 years follow-up.

Secondary

MeasureTime frame
- The effect of surgery on urogenital symptoms and quality of life - Complications of surgery (direct and medium term) - Cost-effectiveness analysis.

Contacts

Public ContactA. Vollebregt

Spaarne Ziekenhuis Hoofddorp Department of Gynaecology

a.vollebregt@umcutrecht.nl+31 (023) 8907540

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)